POLISCOPE
Back to bills
Part ofInsurance →

The civic record

Read. Follow. Verify.
SB 360KANSASSession 2025-2026State Billdead
Did Not Advance

Kansas Legislature enacts consumer prescription protection and accountability act regulating pharmacy benefits managers

Original title: AN ACT concerning insurance; enacting the Kansas consumer prescription protection and accountability act; providing for the regulation of pharmacy benefits managers; requiring the registration of auditing entities; establishing procedures and requirements for the conduct of pharmacy audits, pharmacy benefits manager reporting and examinations; amending K.S.A. 40-222 and 40-3831 and K.S.A. 2025 Supp. 40-202, 40-3821, 40-3822, 40-3823, 40-3824, 40-3825, 40-3826, 40-3827 and 40-3828a and repealing the existing sections; also repealing K.S.A. 40-3828, 65-16,121, 65-16,122, 65-16,123, 65-16,124, 65-16,125 and 65-16,126 and K.S.A. 2025 Supp. 40-3829 and 40-3830.

Last action · April 10, 2026: Died in House Committee

Bill progressHistory & official text ↓
Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

The Kansas Legislature enacts the consumer prescription protection and accountability act to regulate s, establish audit procedures, and require annual licensing and financial reporting. The act prohibits specific reimbursement practices, mandates point-of-sale pass-throughs, and sets auditing standards for prescription drug claims.

Why it matters

s face new oversight rules, fee restrictions, and mandatory reporting requirements affecting how prescription drug claims and audits are handled in Kansas.

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

Pharmacy benefits managers

Pharmacy benefits managers must obtain a valid license, submit to financial examinations, adhere to strict auditing and reimbursement standards, and report aggregate rebate and pricing data.

Directly affected

Pharmacies and pharmacists

Pharmacies and pharmacists receive protection regarding audit timelines, minimum reimbursement thresholds, and restrictions on retroactive fees and chargebacks.

Directly affected

Covered persons

Covered individuals benefit from point-of-sale cost-sharing calculations reduced by drug rebates.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What notice must a pharmacy receive before an audit?
An auditing entity must provide the pharmacy with at least 14 calendar days' prior written notice before conducting an audit.
Are self-funded health plans subject to these rules?
Self-funded health plans subject to ERISA are exempt from the reimbursement and operational provisions of the act.
How are rebates handled for consumers at the point of sale?
A covered individual's defined cost sharing for each prescription drug must be calculated at the point of sale based on a price reduced by an amount equal to at least 100% of all s received or to be received.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Follow the record

Votes, people, money & the original source

Where This Stands

This bill did not become law - Died in committee.

Procedural history

29 actions
  1. Apr 10, 2026House
    Died in House Committee
  2. Apr 9, 2026House
    Withdrawn from House Committee on Health and Human Services; Rereferred to House Committee on Health and Human Services
  3. Mar 17, 2026House
    Withdrawn from House Committee on Insurance; Rereferred to House Committee on Insurance
  4. Mar 13, 2026House
    Withdrawn from House Committee on Health and Human Services; Referred to House Committee on Health and Human Services
  5. Mar 11, 2026House
    Hearing: Wednesday, March 11, 2026, 3:30 PM — Room 218-N
  6. Mar 5, 2026House
    Withdrawn from House Committee on Insurance; Rereferred to House Committee on Insurance
Show 23 earlier actions
  1. Mar 4, 2026House
    Withdrawn from House Committee on Health and Human Services; Referred to House Committee on Health and Human Services
  2. Feb 25, 2026HouseIntroduced
    Received and Introduced
  3. Feb 25, 2026HouseCommittee
    Referred to House Committee on Insurance
  4. Feb 18, 2026Senate
    Committee of the Whole - Now working on
  5. Feb 18, 2026SenateFloor
    Committee of the Whole - Committee Report be adopted
  6. Feb 18, 2026Senate
    Committee of the Whole - Motion to Amend - Offered by
  7. Feb 18, 2026SenateFloor
    Committee of the Whole - Amendment by was adopted
  8. Feb 18, 2026Senate
    Committee of the Whole - Motion to Amend - Offered by
  9. Feb 18, 2026SenateFloor
    Committee of the Whole - Amendment by was adopted
  10. Feb 18, 2026Senate
    Committee of the Whole - Motion to Amend - Offered by
  11. Feb 18, 2026Senate
    Committee of the Whole - Amendment by was withdrawn
  12. Feb 18, 2026Senate
    Committee of the Whole - Motion to Amend - Offered by
  13. Feb 18, 2026Senate
    Committee of the Whole - Amendment by was rejected
  14. Feb 18, 2026Senate
    Committee of the Whole - Motion to Amend - Offered by
  15. Feb 18, 2026Senate
    Committee of the Whole - Amendment by was rejected
  16. Feb 18, 2026SenateFloor
    Committee of the Whole - Be passed as further amended
  17. Feb 18, 2026Senate
    fa_fabc_912
  18. Feb 18, 2026SenateFloor
    Emergency Final Action - Passed as amended
  19. Feb 6, 2026SenateFloor
    Committee Report recommending bill be passed as amended by
  20. Jan 29, 2026Senate
    Hearing continuation: Thursday, January 29, 2026, 9:30 AM — Room 546-S
  21. Jan 28, 2026Senate
    Hearing: Wednesday, January 28, 2026, 9:30 AM — Room 546-S
  22. Jan 23, 2026SenateCommittee
    Referred to Senate Committee on Financial Institutions and Insurance
  23. Jan 22, 2026SenateIntroduced
    Introduced

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

Expanded PBM Oversight and Audit Controls

The bill shifts regulatory oversight by imposing strict timelines, documentation rules, and compensation limits on pharmacy audits conducted by PBMs and third-party payers.

Kansas Department of Insurance

Connected Entities

Kansas Department of Insurance, Senate Committee on Financial Institutions and Insurance, National Association of Insurance Commissioners
OrganizationKansas Department of Insurance“State agency responsible for administering PBM licensing and examinations”Map →
OrganizationSenate Committee on Financial Institutions and Insurance“Legislative committee sponsoring SB 360”Map →
OrganizationNational Association of Insurance Commissioners“Organization providing examiner handbooks and financial regulation standards”Map →

Sources

Open source document

www.kslegislature.gov

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 85)
  • Controversy75
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz40
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record